GlassScriptPhysician profile
Lawrence Tam
NPI 1508242520
$2,694.05
in general payments reported to CMS, 2019-2025
13 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $285 · 2021: $31.03 · 2022: $281 · 2023: $518 · 2024: $127 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714 · Entertainment: $70.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.74 |
| Entertainment | $70.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,134.46 | 2019-2025 | Clariti Contact Lens, Biofinity Contact Lens |
| Johnson & Johnson Vision Care, INC. | $240.22 | 2023 | Acuvue |
| Optos, INC. | $226.40 | 2020-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $190.30 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $179.93 | 2019-2020 | |
| Alcon Vision LLC | $167.05 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Sun Pharmaceutical Industries INC. | $98.17 | 2019 | |
| Bausch & Lomb Americas INC. | $97.24 | 2022-2025 | Infuse |
| Oyster Point Pharma, INC. | $97.14 | 2022 | |
| Mallinckrodt Hospital Products INC. | $95.16 | 2023 | Acthar |
| Rxsight INC | $74.68 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Abbvie INC. | $62.27 | 2022 | |
| Allergan, INC. | $31.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Tam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.